Relationship of Impairment Induced by Intracellular S-adenosylhomocysteine Accumulation with DNA Methylation in Human Umbilical Vein Endothelial Cells Treated with 3-deazaadenosine

Overview

Journal Int J Exp Pathol

Publisher Wiley

Specialty Pathology

Date 2009 Dec 5

PMID 19958400

Citations 6

Authors

Xiaoping Yu

Wenhua Ling

Mantian Mi

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to estimate the relationship of endothelial dysfunction induced by intracellular S-adenosylhomocysteine (SAH) accumulation and DNA methylation in human umbilical vein endothelial cells (HUVEC). The isolated HUVEC were incubated with 3-deazaadenosine (DZA) to induce experimental intracellular SAH accumulation. The impairment of HUVEC function was assessed by changes in morphology and proliferative ability. The expression of DNA methyltransferase-1 (DNMT1) and the atherosclerosis related genes [oestrogen receptor-alpha (ER-alpha), extracellular superoxide dismutase (EC-SOD) and monocyte chemoattractant protein-1 (MCP-1)] were analysed using quantitative real-time PCR. Global DNA methylated status was measured using the cytosine extension assay. The methylated patterns of ER-alpha, EC-SOD and MCP-1 genes were determined with methylation-specific PCR. We found that DZA administration increased intracellular SAH levels progressively and simultaneously decreased Hcy content in medium. Moreover, the supplementation induced HUVEC apoptosis, inhibited proliferation ability and DNMT1 mRNA expression (P < 0.05) and furthermore reduced global DNA methylation status (P < 0.05). Correlation analysis showed the presence of a negative correlation between intracellular SAH concentration, proliferative ability, and expression of ER-alpha, EC-SOD, and DNMT1 (r = -0.89, -0.86, -0.92 and -0.88 respectively, P < 0.001); and a positive correlation with MCP-1 expression and DNA [(3)H]-dCTP incorporation (r = 0.89 and 0.93 respectively, P < 0.001). Our results showed that endothelial dysfunction induced by intracellular SAH accumulation is mediated by regulating the expression of atherosclerosis related genes in HUVEC, which is not related with gene promoter methylated patterns, but may be associated with altered global DNA hypomethylated status. These findings suggest that SAH can act as the potential molecular biological marker in the promotion of atherogenesis.

Citing Articles

A primer on metabolic memory: why existing diabesity treatments fail.

Copur S, Rossing P, Afsar B, Sag A, Siriopol D, Kuwabara M Clin Kidney J. 2021; 14(3):756-767.

PMID: 34512957 PMC: 8422888. DOI: 10.1093/ckj/sfaa143.

Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Fu Y, Wang X, Kong W Br J Pharmacol. 2017; 175(8):1173-1189.

PMID: 28836260 PMC: 5867019. DOI: 10.1111/bph.13988.

Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylation.

Zhang D, Lou J, Zhang X, Zhang L, Wang F, Xu D Oncotarget. 2016; 8(9):15377-15392.

PMID: 28030819 PMC: 5362492. DOI: 10.18632/oncotarget.14165.

Genome-wide methylation and gene expression changes in newborn rats following maternal protein restriction and reversal by folic acid.

Altobelli G, Bogdarina I, Stupka E, Clark A, Langley-Evans S PLoS One. 2014; 8(12):e82989.

PMID: 24391732 PMC: 3877003. DOI: 10.1371/journal.pone.0082989.

Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in endothelial cells.

Wang L, Qiu X, Hao Q, Li D Cell Death Dis. 2013; 4:e551.

PMID: 23519120 PMC: 3615733. DOI: 10.1038/cddis.2013.66.

References

Post W, Goldschmidt-Clermont P, Wilhide C, Heldman A, Sussman M, Ouyang P . Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 2000; 43(4):985-91. DOI: 10.1016/s0008-6363(99)00153-4. View

OGrady H, Kelly C, Bouchier-Hayes D, Leahy A . Homocysteine and occlusive arterial disease. Br J Surg. 2002; 89(7):838-44. DOI: 10.1046/j.1365-2168.2002.02108.x. View

Herman J, Graff J, Myohanen S, Nelkin B, Baylin S . Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996; 93(18):9821-6. PMC: 38513. DOI: 10.1073/pnas.93.18.9821. View

Castro R, Rivera I, Martins C, Struys E, Jansen E, Clode N . Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J Mol Med (Berl). 2005; 83(10):831-6. DOI: 10.1007/s00109-005-0679-8. View

Fu W, Dudman N, Perry M, Young K, Wang X . Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochem Biophys Res Commun. 2000; 271(1):47-53. DOI: 10.1006/bbrc.2000.2587. View

Brattstrom L, Wilcken D . Homocysteine and cardiovascular disease: cause or effect?. Am J Clin Nutr. 2000; 72(2):315-23. DOI: 10.1093/ajcn/72.2.315. View

Hiltunen M, Yla-Herttuala S . DNA methylation, smooth muscle cells, and atherogenesis. Arterioscler Thromb Vasc Biol. 2003; 23(10):1750-3. DOI: 10.1161/01.ATV.0000092871.30563.41. View

McCully K . Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969; 56(1):111-28. PMC: 2013581. View

Boers G . Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin Thromb Hemost. 2000; 26(3):291-5. DOI: 10.1055/s-2000-8096. View

10.

Melnyk S, Pogribna M, Pogribny I, Yi P, James S . Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations. Clin Chem. 2000; 46(2):265-72. View

11.

Yi P, Melnyk S, Pogribna M, Pogribny I, Hine R, James S . Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem. 2000; 275(38):29318-23. DOI: 10.1074/jbc.M002725200. View

12.

Naushad S, Jamal N, Angalena R, Prasad C, Devi A . Hyperhomocysteinemia and the compound heterozygous state for methylene tetrahydrofolate reductase are independent risk factors for deep vein thrombosis among South Indians. Blood Coagul Fibrinolysis. 2007; 18(2):113-7. DOI: 10.1097/MBC.0b013e3280108e01. View

13.

Pandey S, Vaidya A, Vaidya R, Talwalkar S . Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality. J Assoc Physicians India. 2007; 54:769-74. View

14.

Hiltunen M, Turunen M, Hakkinen T, Rutanen J, Hedman M, Makinen K . DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med. 2002; 7(1):5-11. DOI: 10.1191/1358863x02vm418oa. View

15.

Hopkins P, Wu L, Hunt S, James B, Vincent G, Williams R . Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1997; 17(11):2783-92. DOI: 10.1161/01.atv.17.11.2783. View

16.

Clarke R . Homocysteine and cardiovascular disease. Overview. J Cardiovasc Risk. 1999; 5(4):213-5. DOI: 10.1097/00043798-199808000-00001. View

17.

Lentz S, Piegors D, MALINOW M, Heistad D . Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys. Circulation. 2001; 103(7):1006-11. DOI: 10.1161/01.cir.103.7.1006. View

18.

Dayal S, Bottiglieri T, Arning E, Maeda N, MALINOW M, Sigmund C . Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res. 2001; 88(11):1203-9. DOI: 10.1161/hh1101.092180. View

19.

Fruchart J, Nierman M, Stroes E, Kastelein J, Duriez P . New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004; 109(23 Suppl 1):III15-9. DOI: 10.1161/01.CIR.0000131513.33892.5b. View

20.

Zaina S, Lindholm M, Lund G . Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia?. J Nutr. 2004; 135(1):5-8. DOI: 10.1093/jn/135.1.5. View